Published in Cell · View the paper (DOI)
A new AI platform can diagnose two common retinal diseases and rate their severity with over 95% accuracy, as well as distinguish between viral and bacterial pneumonia. This technology has the potential to improve patient outcomes and increase access to care in remote areas.
Coverage from 2 institutions